BACKGROUND: The wide area of application, including coronary artery disease, valvular heart disease, or pulmonary hypertension makes stress echocardiography (SE) a powerful, cost-effective imaging modality in cardiology. The role of this technique in clinical practice in Austria is unknown. METHODS: A nationwide survey included all departments for cardiology and/or internal medicine in the years 2008 and 2013. By electronic questionnaire demographics, indication for the test, the numbers of examined cases per year, operators, and various applied techniques of SE were interrogated and completed by telephone interviews. RESULTS: Data could be obtained from all 117 departments. In the year 2007 in 58 (50%) and in 2012 57 (49%) departments SE was available in Austrian hospitals. More than 100 SEs per year were performed by only four (7%) units in the year 2007 and by five (8%) in 2012. Physical exercise, dobutamine, and dipyridamole SE were available in 27 (46%), 52 (90%), and six (10%) units in 2007, and in 15 (27%), 52 (91%), and five (9%) units in 2012, respectively. In 2007 41 (71%) and in 2012 26 (46%) echo-labs administered contrast agents during SE. Transesophageal SE and 3D-echo was performed in one (2%) and three (5%) units in 2007, and in six (10%) and four (7%) echo-labs in 2012. CONCLUSIONS: This representative survey demonstrates the underuse of SE in clinical practice in Austria. Even in established application fields performance is low, examination frequencies as recommended by the cardiology societies are fulfilled only by a minority of institutions.
BACKGROUND: The wide area of application, including coronary artery disease, valvular heart disease, or pulmonary hypertension makes stress echocardiography (SE) a powerful, cost-effective imaging modality in cardiology. The role of this technique in clinical practice in Austria is unknown. METHODS: A nationwide survey included all departments for cardiology and/or internal medicine in the years 2008 and 2013. By electronic questionnaire demographics, indication for the test, the numbers of examined cases per year, operators, and various applied techniques of SE were interrogated and completed by telephone interviews. RESULTS: Data could be obtained from all 117 departments. In the year 2007 in 58 (50%) and in 2012 57 (49%) departments SE was available in Austrian hospitals. More than 100 SEs per year were performed by only four (7%) units in the year 2007 and by five (8%) in 2012. Physical exercise, dobutamine, and dipyridamole SE were available in 27 (46%), 52 (90%), and six (10%) units in 2007, and in 15 (27%), 52 (91%), and five (9%) units in 2012, respectively. In 2007 41 (71%) and in 2012 26 (46%) echo-labs administered contrast agents during SE. Transesophageal SE and 3D-echo was performed in one (2%) and three (5%) units in 2007, and in six (10%) and four (7%) echo-labs in 2012. CONCLUSIONS: This representative survey demonstrates the underuse of SE in clinical practice in Austria. Even in established application fields performance is low, examination frequencies as recommended by the cardiology societies are fulfilled only by a minority of institutions.
Authors: Christian W Hamm; Jean-Pierre Bassand; Stefan Agewall; Jeroen Bax; Eric Boersma; Hector Bueno; Pio Caso; Dariusz Dudek; Stephan Gielen; Kurt Huber; Magnus Ohman; Mark C Petrie; Frank Sonntag; Miguel Sousa Uva; Robert F Storey; William Wijns; Doron Zahger Journal: Eur Heart J Date: 2011-08-26 Impact factor: 29.983
Authors: Bogdan A Popescu; Alexandros Stefanidis; Petros Nihoyannopoulos; Kevin F Fox; Simon Ray; Nuno Cardim; Fausto Rigo; Luigi P Badano; Alan G Fraser; Fausto Pinto; Jose Luis Zamorano; Gilbert Habib; Gerald Maurer; Patrizio Lancellotti Journal: Eur Heart J Cardiovasc Imaging Date: 2014-11 Impact factor: 6.875
Authors: Abdellaziz Dahou; Philipp Emanuel Bartko; Romain Capoulade; Marie-Annick Clavel; Gerald Mundigler; Samuel Larue Grondin; Jutta Bergler-Klein; Ian Burwash; Jean G Dumesnil; Mario Sénéchal; Kim O'Connor; Helmut Baumgartner; Philippe Pibarot Journal: Circ Cardiovasc Imaging Date: 2015-03 Impact factor: 7.792
Authors: A H Gershlick; M de Belder; J Chambers; D Hackett; R Keal; A Kelion; S Neubauer; D J Pennell; M Rothman; M Signy; P Wilde Journal: Heart Date: 2007-04 Impact factor: 5.994
Authors: Abdou Elhendy; Edward L O'Leary; Feng Xie; Anna C McGrain; James R Anderson; Thomas R Porter Journal: J Am Coll Cardiol Date: 2004-12-07 Impact factor: 24.094
Authors: Jeane M Tsutsui; Abdou Elhendy; James R Anderson; Feng Xie; Anna C McGrain; Thomas R Porter Journal: Circulation Date: 2005-08-29 Impact factor: 29.690
Authors: Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau Journal: Eur Heart J Date: 2009-08-27 Impact factor: 29.983